Teza Capital Management’s Select Medical SEM Stock Holding History

Teza Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,261	Closed	-$215K	–	743
2024 Q1	$215K	Sell	13,261 -13,571	-51%	-$199K	0.03%	499
2023 Q4	$340K	Buy	+26,832	New	+$339K	0.06%	381
2021 Q3	–	Sell	-13,777	Closed	-$314K	–	562
2021 Q2	$314K	Sell	13,777 -2,866	-17%	-$59.5K	0.05%	425
2021 Q1	$306K	Buy	+16,643	New	+$273K	0.06%	374

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Teza Capital Management's SEM Position: Q2 2024 in Review

Teza Capital Management sold out of Select Medical (SEM) in Q2 2024, closing a stake of 13,261 shares — an estimated $215K sold.

Teza Capital Management first reported a position in SEM in Q1 2021 and held it in 4 quarters. The position peaked at $340K in Q4 2023. 256 funds tracked by Wall St. Rank hold SEM as of Q2 2024.

Teza Capital Management reported no remaining Select Medical position as of Q2 2024 after selling out during the quarter.
Teza Capital Management sold 13,261 Select Medical shares in Q2 2024, an estimated $215K.
Teza Capital Management first reported a position in Select Medical in Q1 2021 and held it in 4 quarters.
Teza Capital Management's Select Medical position peaked at $340K in Q4 2023.
256 funds tracked by Wall St. Rank held Select Medical as of Q2 2024.

Based on Teza Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.